Independent prescribing is the most significant scope expansion available to UK pharmacists. It authorises you to prescribe any medicine within your competence — including controlled drugs — for any condition within your scope of practice. From 2026, all new pharmacist graduates trained under the IETP 2021 standards will qualify as independent prescribers at the point of registration. For experienced pharmacists, a separate GPhC-accredited prescribing course is the route.
Entry Requirements
To enrol on a GPhC-accredited independent prescribing course, you need: GPhC registration as a pharmacist. Minimum 2 years post-registration experience (most courses specify this). A Designated Prescribing Practitioner (DPP) — a doctor, dentist, or experienced prescriber who will supervise your clinical learning in practice. Evidence of relevant clinical experience in your intended prescribing area. A supporting statement from your employer confirming clinical access and supervision arrangements.
The DPP requirement is the most common barrier. You need a named clinical supervisor willing to provide 90+ hours of supervised prescribing practice — including observed consultations, case-based discussions, and sign-off of prescribing competencies. Securing a DPP before applying to the course is essential.
What the Course Covers
GPhC-accredited independent prescribing courses are delivered by universities (typically over 6-12 months, part-time). The taught component covers: prescribing governance and legislation, consultation skills for pharmacist prescribers, clinical pharmacology and therapeutics applied to prescribing decisions, evidence-based prescribing, prescribing for specific populations (paediatrics, elderly, pregnancy), and controlled drug prescribing.
The practice component requires: 90 hours minimum of supervised prescribing practice with your DPP, portfolio of prescribing encounters, reflective accounts, case-based discussions, and a final assessment (typically a portfolio submission plus a clinical examination or viva).
Cost
Course fees typically range from £1,500 to £3,500 depending on the provider and format (fully online vs blended). NHS-funded places may be available through your local Integrated Care Board (ICB) or employer — check with your pharmacy lead or workforce development team. HEE (Health Education England) has funded prescribing courses in previous years through the Pharmacy Integration Fund.
Total investment: Course fees + DPP time (opportunity cost) + study time. Most pharmacists describe the year as demanding but worthwhile — particularly those who already work in clinical roles where prescribing competence is needed daily.
How It Changes Your Practice
In community pharmacy: Prescribe within Pharmacy First pathways without PGD limitations. Prescribe for long-term conditions within your competence (hypertension, diabetes, respiratory). Manage patients independently rather than referring to GP for every prescription change.
In hospital pharmacy: Prescribe on wards within your specialty area. Contribute to MDT prescribing decisions. Manage drug-level-guided dosing (e.g., vancomycin, gentamicin) independently. Reduce medical staff prescribing burden.
In primary care pharmacy (PCN roles): The most transformative scope change. Independent prescribers in PCN pharmacy roles can manage long-term condition reviews, medication optimisation, and acute presentations independently — significantly expanding the capacity of primary care.
Preparing for the Prescribing Assessment
The prescribing course assessment typically includes portfolio submission, clinical viva or OSCE, and a prescribing safety assessment. The clinical knowledge required overlaps significantly with CRA content — applied therapeutics, drug interactions, monitoring, and patient safety.
iatroX Q-bank content covers the therapeutic knowledge that underpins prescribing decisions — and Ask iatroX provides instant BNF/NICE-grounded answers to prescribing queries during your training year.